Biomea Fusion Inc Share Price

NASDAQ: BMEA

Small Cap

$1.97

+0.04

(+1.81%)

as on September 16, 2025 at 1:29 am IST

$₹

Biomea Fusion Inc Stock Performance

as on September 16, 2025 at 1:29 am IST

Day's Low
$1.86
Day's Price Range
$1.97
$1.97
5.58%
Downside
52 Week's Low
52 Week's High
$1.29
52-Week Price Range
$13.07
$1.97
34.49%
Downside
563.45%
Upside

Biomea Fusion Inc share price movements today

Previous Close: $1.93
Open: $1.93
Volume: 896.9K
Day's Low - High: $1.86 - $1.97
52 Week Low - High: $1.29 - $13.07

Biomea Fusion Inc Historical Returns

1 Month Return: + 13.29 %
3 Month Return: -25.48 %
1 Year Return: -75.44 %
3 Year Return: -83.15 %
5 Year Return: 0 %

Biomea Fusion Inc Stock Fundamentals & Key Indicators

Check Biomea Fusion Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$114.9M

EPS (TTM)

-1.5296

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

P/B Ratio

PEG Ratio

EBITDA

-113.3M

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

1636008700.00%

Biomea Fusion Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Biomea Fusion Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Biomea Fusion Inc	BUY	$114.9M	NA	NA	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$61.1B	251.26%	-505.15	-12.96%
Beone Medicines Ltd	NA	$38.7B	NA	NA	-3.89%
Vertex Pharmaceuticals Incorporated	BUY	$101.2B	47.46%	28.09	31.86%
Regeneron Pharmaceuticals, Inc.	BUY	$59.6B	0.6%	14.1	31.37%

Stock Returns calculator for Biomea Fusion Inc Stock including INR - Dollar returns

The Biomea Fusion Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Biomea Fusion Inc investment value today

Current value as on today

₹29,554

Returns

₹70,446

(-70.45%)

Returns from Biomea Fusion Inc Stock

₹75,313 (-75.31%)

Dollar Returns*

₹4,867 (+4.87%)

Analyst Recommendation on Biomea Fusion Inc Stock

Based on 14 analysts

BUY

85.71%

Buy

14.29%

Hold

0.00%

Sell

Based on 14 analysts, 85.71% of analysts recommend a 'BUY' rating for Biomea Fusion Inc. Average target price of $7.29

Biomea Fusion Inc Share Price Target

Get share price movements and forecasts by analysts on Biomea Fusion Inc.

What analysts predicted

72.98%UPSIDE

Target Price

$7.29

Current Price

$1.97

Analyzed by

14 Analysts

Target

$7.29

Biomea Fusion Inc target price $7.29, a slight upside of 72.98% compared to current price of $1.97. According to 14 analysts rating.

Biomea Fusion Inc Stock's Interest Amongst Investors

Search interest for Biomea Fusion Inc Stock has increased by 24% in the last 30 days, reflecting an upward trend in search activity.

Time period: August 17, 2025 to September 16, 2025

Change:24% versus previous 30 day period

Biomea Fusion Inc Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	-	-	-	6	-	-	-	1	-	-
Gross Profit	0	-1	-1	5	0	0	0	1	-	0
Operating Income	-30	-27	-31	-37	-41	-38	-34	-30	-29	-21
EBITDA	-29	-27	-30	-36	-40	-38	-33	-29	-29	-20
Interest Expense	0	-	-	0	-	-	-	-	-	-
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-29	-24	-28	-34	-39	-37	-32	-29	-29	-20
Income Tax Expense	0	0	0	1	0	-	0	-	-	-
Net Income	-29	-24	-28	-34	-39	-37	-32	-29	-29	-20
Net Profit Margin	0.00%	0.00%	0.00%	-567.96%	0.00%	0.00%	0.00%	-2401.80%	0.00%	0.00%

Biomea Fusion Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	-	-	-	-	-	-
Gross Profit	-	0	0	-1	-4	-
Operating Income	-1	-5	-41	-83	-126	-144
EBITDA	-1	-5	-41	-82	-124	-136
Interest Expense	-	-	0	1	-	-
Depreciation	-	0	0	0	1	1
Income Before Tax	-1	-5	-41	-81	-117	-138
Income Tax Expense	0	0	0	-1	-	-
Net Income	-1	-5	-41	-80	-117	-138
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Biomea Fusion Inc Quarterly Cash Flow

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Net Income	-24	-28	-34	-39	-37	-32	-29	-29	-20
Operating Cash Flow	-25	-23	-22	-32	-32	-25	-30	-25	-19
Investing Cash Flow	0	0	0	0	0	0	0	-	-
Financing Cash Flow	162	0	0	0	1	0	0	3	39
Change in Cash	136	-23	-22	-31	-31	-24	-29	-22	20

Biomea Fusion Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-5	-41	-81	-117	-138
Operating Cash Flow	-4	-35	-62	-96	-119
Investing Cash Flow	0	-33	27	-2	0
Financing Cash Flow	65	153	1	163	1
Change in Cash	61	84	-33	64	-118

Global Institutional Holdings in Biomea Fusion Inc

Funds	Holdings
FMR Inc	9.35%
Cormorant Asset Management, LLC	6.14%
BlackRock Inc	3.72%
Vanguard Group Inc	2.37%
Aisling Capital Management LP	1.37%

See all

Insights on Biomea Fusion Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 70.6% return, outperforming this stock by 146.0%
NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 116.5% return, outperforming this stock by 199.6%
NEGATIVE IMPACT
Price Dip
In the last 3 months, BMEA stock has moved down by -25.5%

About Biomea Fusion Inc

biomea fusion, llc was formed in 2017 by a small group of biotech executives. we are dedicated to developing innovative medicines for patients. it is our goal to design and clinically develop patient friendly therapies with higher efficacy than the current standard of care. the more precise a therapeutic agent is, the better the potential outcomes for individual patients’ needs. we are a precision oncology company developing novel small molecules that target aggressive forms of cancer. patients with these aggressive tumors typically exhibit high mortality rates and suffer from inadequate treatment options. with our current program, we are targeting specific changes to the dna of patients, which can be isolated as key drivers for tumor growth. we leverage our internal expertise and compliment it with computational drug design technology to build novel medicines for the future. we have significantly invested in the upfront development of our targeted therapies and are conducting bro

Organisation	Biomea Fusion Inc
Headquarters	1599 Industrial Road, San Carlos, CA, United States, 94070
Industry	Healthcare
CEO	Dr. Michael J. M. Hitchcock Ph.D.
E-voting on shares	Click here to vote

Key Management of Biomea Fusion Inc

Name	Title
Dr. Thorsten Kirschberg Ph.D.	Executive Vice President of Chemistry
Dr. Stephan Morris M.D.	Chief Development Officer
Mr. Ravi Upasani Ph.D.	Executive Vice President of Intellectual Property
Dr. Juan Pablo Frias M.D.	Chief Medical Officer & Member of Scientific Advisory Board
Caroline Perez- Dupont J.D.	Senior Vice President of Contracts
Dr. Michael J. M. Hitchcock Ph.D.	Interim CEO & Director
Mr. Ramses M. Erdtmann	Co-Founder, President, COO & Director
Mr. Heow Tan	Chief Technology & Quality Officer

FAQs

What is Biomea Fusion Inc share price today?

Biomea Fusion Inc share price today is $1.97 as on September 16, 2025 at 1:29 am IST at the close of the market. Biomea Fusion Inc share today touched a day high of $1.97 and a low of $1.86.

What is the 52 week high and 52 week low for Biomea Fusion Inc share?

Biomea Fusion Inc share touched a 52 week high of $13.07 on October 9, 2024 and a 52 week low of $1.29 on May 28, 2025. Biomea Fusion Inc stock price today i.e. September 16, 2025 at 1:29 am IST is closed at $1.97,which is 84.93% down from its 52 week high and 52.65% up from its 52 week low.

What is Biomea Fusion Inc's market capitalisation today?

Biomea Fusion Inc market capitalisation is $0.00T as on September 16, 2025 at 1:29 am IST.

How to invest in Biomea Fusion Inc Stock (BMEA) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Biomea Fusion Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Biomea Fusion Inc Shares that will get you 0.7614 shares as per Biomea Fusion Inc share price of $1.97 per share as on September 16, 2025 at 1:29 am IST.

What is the minimum amount required to buy Biomea Fusion Inc Stock (BMEA) from India?

Indian investors can start investing in Biomea Fusion Inc (BMEA) shares with as little as ₹88.042 or $1 (as of September 16, 2025 at 5:44 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹880.42 in Biomea Fusion Inc stock (as per the Rupee-Dollar exchange rate as on September 16, 2025 at 5:44 pm IST). Based on Biomea Fusion Inc share’s latest price of $1.97 as on September 16, 2025 at 1:29 am IST, you will get 5.0761 shares of Biomea Fusion Inc. Learn more about fractional shares .